KR19990011062A - Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same - Google Patents

Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same Download PDF

Info

Publication number
KR19990011062A
KR19990011062A KR1019970034003A KR19970034003A KR19990011062A KR 19990011062 A KR19990011062 A KR 19990011062A KR 1019970034003 A KR1019970034003 A KR 1019970034003A KR 19970034003 A KR19970034003 A KR 19970034003A KR 19990011062 A KR19990011062 A KR 19990011062A
Authority
KR
South Korea
Prior art keywords
liquid crystal
crystal compound
group
ring
reaction mixture
Prior art date
Application number
KR1019970034003A
Other languages
Korean (ko)
Inventor
이찬재
브이 베즈보로도프
어기한
Original Assignee
손욱
삼성전관 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 손욱, 삼성전관 주식회사 filed Critical 손욱
Priority to KR1019970034003A priority Critical patent/KR19990011062A/en
Publication of KR19990011062A publication Critical patent/KR19990011062A/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

본 발명은 이소옥사졸리딘 고리 함유 액정 화합물과 이를 포함하고 있는 액정 조성물을 개시한다. 본 발명에 따른 이소옥사졸리딘 고리 함유 액정 화합물은 화학적으로 안정하고, 결정성 고체로부터 스멕틱상으로 전이되는 온도가 낮기 때문에 스멕틱상을 형성하기가 매우 용이하다. 이러한 액정 화합물은 액정 조성물의 구성요소로 이용될 뿐만 아니라, 합성 중간체로서 다른 종류의 액정 화합물을 합성하는데 이용될 수 있다. 본 발명에 따른 액정 화합물을 포함하고 있는 액정 조성물은 복굴절율, 유전율 이방성 등을 적절히 조절하면 여러 가지 액정표시소자에 매우 유용하게 적용할 수 있다.The present invention discloses an isoxazolidine ring-containing liquid crystal compound and a liquid crystal composition containing the same. The isoxazolidine ring-containing liquid crystal compound according to the present invention is chemically stable, and it is very easy to form a smectic phase because of the low temperature transition from the crystalline solid to the smectic phase. Such a liquid crystal compound may be used not only as a component of the liquid crystal composition but also to synthesize other kinds of liquid crystal compounds as a synthetic intermediate. The liquid crystal composition containing the liquid crystal compound according to the present invention can be very usefully applied to various liquid crystal display devices by appropriately adjusting birefringence, dielectric anisotropy, and the like.

Description

이소옥사졸리딘 고리 함유 액정 화합물 및 이를 포함하고 있는 액정 조성물Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same

본 발명은 이소옥사졸리딘(isoxazolidine) 고리를 함유하고 있는 액정 화합물 및 이를 포함하고 있는 액정 조성물에 관한 것이다.The present invention relates to a liquid crystal compound containing an isoxazolidine ring and a liquid crystal composition containing the same.

오각형의 헤테로고리를 포함하고 있는 액정 화합물은 많이 알려져 있다. 그 중에서도 특히 질소(N)와 산소(O) 원자를 갖고 있는 오각형의 헤테로고리 함유 화합물에 관한 연구가 다양하게 이루어지고 있는데, 그 대표적인 예로서 이소옥사졸(isoxazole) 고리 함유 화합물 (A), 옥사졸(oxazole) 고리 함유 화합물 (B), 옥사디아졸(oxadiazole) 고리 함유 화합물 (C), 벤조옥사졸(benzoxazole) 고리 함유 화합물 (D) 등이 있다.Many liquid crystal compounds containing pentagonal heterocycles are known. In particular, various studies have been conducted on pentagonal heterocyclic-containing compounds having nitrogen (N) and oxygen (O) atoms. Representative examples thereof include isoxazole ring-containing compounds (A) and oxa. Oxazole ring-containing compounds (B), oxadiazole ring-containing compounds (C), and benzoxazole ring-containing compounds (D).

그런데 상기 화합물들은 일반적으로 결정성 고체-스메틱상 전이온도를 지나치게 높아 스멕틱상 형성이 용이하지 않다는 문제점이 있다.However, the compounds generally have a problem that the formation of the smectic phase is not easy because the crystalline solid-smetic phase transition temperature is too high.

본 발명이 이루고자 하는 첫번째 과제는 상기 문제점을 해결하여 종래보다 결정성 고체-스멕틱상 전이온도가 낮아진 이소옥사졸리딘 고리 함유 액정 화합물을 제공하는 것이다.The first object of the present invention is to solve the above problems and to provide an isoxazolidine ring-containing liquid crystal compound having a lower crystalline solid-smectic transition temperature than in the related art.

본 발명이 이루고자 하는 두번째 기술적 과제는 상기 액정 화합물을 포함하고 있는 액정 조성물을 제공하는 것이다.The second technical problem to be achieved by the present invention is to provide a liquid crystal composition containing the liquid crystal compound.

상기 첫번째 과제를 이루기 위하여 본 발명에서는, 화학식 1의 이소옥사졸리딘 고리 함유 액정 화합물을 제공한다.In order to achieve the first object, the present invention provides an isoxazolidine ring-containing liquid crystal compound of the formula (1).

상기식중, R1과 R2중의 적어도 하나는 하기 구조식으로 표시되는 그룹이고,Wherein at least one of R 1 and R 2 is a group represented by the following structural formula,

여기에서, Z1는 COO, OOC, CH2CH2, OCH2, CH2O, C≡C, CH=CH 또는 CH2이고,Wherein Z 1 is COO, OOC, CH 2 CH 2 , OCH 2 , CH 2 O, C≡C, CH = CH or CH 2 ,

X1, X2, X3, X4, X5, X5, X7그리고 X8은 서로에 관계없이, H, F 또는 Cl이고, R3는 CnH2n+1, OCnH2n+1, SCnH2n+1, C(=O)CnH2n+1, OOC-CnH2n+1, COOCnH2n+1, 또는 NHCnH2n+1(단, n는 1-12의 정수임);X 1 , X 2 , X 3 , X 4 , X 5 , X 5 , X 7 and X 8 are independently of each other, H, F or Cl, and R 3 is C n H 2n + 1 , OC n H 2n +1 , SC n H 2n + 1 , C (= 0) C n H 2n + 1 , OOC-C n H 2n + 1 , COOC n H 2n + 1 , or NHC n H 2n + 1 , where n is An integer of 1-12);

나머지 R1또는 R2는 비치환된 C1∼C12직쇄형 또는 분지형 알킬기, F, Cl, Br, CF3, OCF3및 CN중에서 선택된 적어도 하나의 치환기로 치환된 C1∼C12직쇄형 또는 분지형 알킬기(단, 한 개의 -CH2- 또는 인접하지 않은 두 개의 -CH2-는 -O-, -S-, -CO-, -OCO-, -COO-, -OCS-, -COS- 및 -CH=CH-에 의하여 치환되어 있으며, 말단기(terminal group)로서 -CH=CH2및/또는 -CH=C(CH3)2를 갖고 있음), 사이클로헥실기, 페닐기, 4-알킬사이클로헥실기, 4-알킬페닐기, 4-알콕시페닐기(단, 알킬기는 C1∼C6알킬기임)중에서 선택된 하나이다.The remaining R 1 or R 2 is unsubstituted C 1 ~C 12 straight-chain or branched alkyl, F, Cl, Br, CF 3, OCF 3 and substituted with at least one substituent selected from C 1 ~C 12 straight-CN A chain or branched alkyl group, provided that one -CH 2 -or two non-adjacent -CH 2 -is -O-, -S-, -CO-, -OCO-, -COO-, -OCS-,- Substituted by COS- and -CH = CH- and having -CH = CH 2 and / or -CH = C (CH 3 ) 2 as a terminal group), a cyclohexyl group, a phenyl group, 4 -An alkylcyclohexyl group, a 4-alkylphenyl group, or a 4-alkoxyphenyl group, provided that the alkyl group is a C 1 to C 6 alkyl group.

본 발명의 두번째 과제는 이소옥사졸리딘 고리 함유 액정 화합물을 포함하고 있는 액정 조성물에 의하여 이루어진다.A second object of the present invention is achieved by a liquid crystal composition containing an isoxazolidine ring-containing liquid crystal compound.

바람직하기로는, 상기 R1과 R2중의 적어도 하나는Preferably, at least one of R 1 and R 2

로 이루어진 군으로부터 선택된다(상기식중, Z3는 화학결합(chemical bond)으로서, 산소원자, 황원자 또는 카르복실기이고, R4는 C6∼C12직쇄형 또는 분지형 포화알킬기임).(Wherein Z 3 is a chemical bond, an oxygen atom, a sulfur atom or a carboxyl group, and R 4 is a C 6 -C 12 straight or branched saturated alkyl group).

본 발명에 따른 액정 화합물은 화학식 2의 1,4-디페닐이소옥사졸리딘(1,4-diphenylisoxazolidine)계 화합물, 화학식 3의 1-페닐-4-알킬이소옥사졸리딘(1-phenyl-4-alkylisoxazolidine)계 화합물, 화학식 4 및 5의 비페닐이소옥사졸리딘(biphenylisoxazolidine)계 화합물 및 화학식 6의 사이클로페닐이소옥사졸리딘(cyclophenylisoxazolidine)계 화합물인 것이 특히 바람직하다.The liquid crystal compound according to the present invention is a 1,4-diphenylisoxazolidine compound of Formula 2, 1-phenyl-4-alkylisoxazolidine of Formula 3 (1-phenyl-4 Particularly preferred are -alkylisoxazolidine-based compounds, biphenylisoxazolidine-based compounds of the formulas (4) and (5) and cyclophenylisoxazolidine-based compounds of the formula (6).

상기식중, Y1, Y2, Y3, Y4, Y5, Y6, Y7및 Y8는 서로에 관계없이 CnH2n+1(n은 1 내지 8의 수임)이다.Wherein Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 , Y 7 and Y 8 are C n H 2n + 1 (n is a number from 1 to 8) irrespective of each other.

반응식 1을 참조하여, 상기 화학식 2로 표시되는 1,4-디페닐이소옥사졸리딘계 액정 화합물의 제조방법을 살펴보기로 한다.Referring to Scheme 1, a method for preparing a 1,4-diphenylisooxazolidine-based liquid crystal compound represented by Formula 2 will be described.

먼저, 4-하이드록시벤즈알데히드 (E-1)과 알킬 할라이드를 반응시켜 4-알콕시벤즈알데히드 (E-2)를 제조한다. 이어서, 4-알콕시벤즈알데히드 (E-2)를 대응하는 옥심(oxime) 화합물 (E-3)로 만든 다음, 이를 N-클로로숙신이미드(N-chlorosuccinimide: NCS)와 반응시켜 1-(4'-알콕시페닐)-4-(4-아세톡시페닐)이소옥사졸리딘 (E-4)을 형성한다. 1-(4'-알콕시페닐)-4-(4-아세톡시페닐)이소옥사졸리딘 (E-4)을 가수분해한다.First, 4-alkoxybenzaldehyde (E-1) is reacted with an alkyl halide to produce 4-alkoxybenzaldehyde (E-2). Subsequently, 4-alkoxybenzaldehyde (E-2) is made of the corresponding oxime compound (E-3), which is then reacted with N-chlorosuccinimide (NCS) to give 1- (4 '). -Alkoxyphenyl) -4- (4-acetoxyphenyl) isoxazolidine (E-4). Hydrolyze 1- (4'-alkoxyphenyl) -4- (4-acetoxyphenyl) isooxazolidine (E-4).

가수분해로 얻어진 화합물 (E-5)의 하이드록시기를 알콕시기로 변화시켜 1-(4'-알콕시페닐)-4-(4-알콕시페닐)이소옥사졸리딘을 제조한다.The hydroxyl group of the compound (E-5) obtained by hydrolysis is changed to an alkoxy group to prepare 1- (4'-alkoxyphenyl) -4- (4-alkoxyphenyl) isoxazolidine.

반응식 2를 참조하여, 상기 화학식 3으로 표시되는 1-페닐-4-알킬이소옥사졸리딘계 액정 화합물의 제조방법을 살펴보기로 한다.Referring to Scheme 2, a method for preparing a 1-phenyl-4-alkylisoxazolidine-based liquid crystal compound represented by Chemical Formula 3 will be described.

4-알콕시벤조산 (F-1)으로부터 4-(4'-알콕시페닐카르보닐옥시)벤즈알데히드(F-2)를 형성한 다음, 대응하는 옥심 화합물 (F-3)을 형성한다. 이 옥심 화합물 (F-3)을 N-클로로숙신이미드와 반응시켜 1-(4'-알콕시페닐카르보닐옥시페닐)-4-알킬이소옥사졸리딘을 형성한다.4- (4'-alkoxyphenylcarbonyloxy) benzaldehyde (F-2) is formed from 4-alkoxybenzoic acid (F-1), and then the corresponding oxime compound (F-3) is formed. This oxime compound (F-3) is reacted with N-chlorosuccinimide to form 1- (4'-alkoxyphenylcarbonyloxyphenyl) -4-alkylisooxazolidine.

반응식 3을 참조하여, 화학식 4로 표시되는 비페닐이소옥사졸리딘계 액정 화합물의 제조방법을 살펴보기로 한다.With reference to Scheme 3, a method for preparing a biphenylisoxazolidine-based liquid crystal compound represented by Formula 4 will be described.

4-(4'-알킬페닐)벤조에이트 (G-1)를 환원시켜 4-(4'-알킬페닐)벤질알콜 (G-2)을 제조한다. 이 화합물 (G-2)를 산화시켜 4-(4'-알킬페닐)벤즈알데히드 (G-3)을 형성한다.4- (4'-alkylphenyl) benzoate (G-1) is reduced to produce 4- (4'-alkylphenyl) benzyl alcohol (G-2). This compound (G-2) is oxidized to form 4- (4'-alkylphenyl) benzaldehyde (G-3).

상기 알데히드 화합물 (G-3)을 대응하는 옥심 화합물 (G-4)로 형성한 다음, N-클로로숙신이미드와 반응시켜 1-(4'-알킬비페닐)-4-알킬이소옥사졸리딘을 제조한다.The aldehyde compound (G-3) is formed of the corresponding oxime compound (G-4) and then reacted with N-chlorosuccinimide to form 1- (4'-alkylbiphenyl) -4-alkylisooxazolidine To prepare.

반응식 4를 참조하여, 화학식 5로 표시되는 비페닐이소옥사졸리딘계 액정 화합물의 제조방법을 살펴보기로 한다.With reference to Scheme 4, a method for preparing a biphenylisoxazolidine-based liquid crystal compound represented by Formula 5 will be described.

4-아세틸-4'-알킬비페닐 (H-1)을 환원시켜 4-알킬-4'-(1-하이드록시에틸)비페닐 (H-2)을 형성한다. 이 화합물로부터 물을 제거하여 4-알킬-4'-비닐비페닐 (H-3)을 형성한다.4-acetyl-4'-alkylbiphenyl (H-1) is reduced to form 4-alkyl-4 '-(1-hydroxyethyl) biphenyl (H-2). Water is removed from this compound to form 4-alkyl-4'-vinylbiphenyl (H-3).

한편, 화합물 (H-4)로부터 대응하는 옥심 화합물 (H-5)를 형성한 다음, N-클로로숙신이미드 등과 같은 할로겐화제를 이용하여 화합물 (H-6)을 형성한다.On the other hand, the corresponding oxime compound (H-5) is formed from compound (H-4), and then compound (H-6) is formed using a halogenating agent such as N-chlorosuccinimide or the like.

그 후, 상기 4-알킬-4'-비닐비페닐 (H-3)과 화합물 (H-6)을 반응시켜 화학식 5의 화합물을 형성한다.Thereafter, the 4-alkyl-4'-vinylbiphenyl (H-3) is reacted with compound (H-6) to form a compound of formula (5).

반응식 5를 참조하여, 화학식 6으로 표시되는 사이클로헥실페닐이소옥사졸리딘(cyclohexylphenylisoxazolidine)계 액정 화합물의 제조방법을 살펴보기로 한다.Referring to Scheme 5, a method for preparing a cyclohexylphenylisoxazolidine-based liquid crystal compound represented by Chemical Formula 6 will be described.

4-(4'-알킬사이클로헥실)벤즈알데히드 (I-1)로부터 그에 대응하는 옥심 화합물(I-2)을 형성한다. 상기 옥심 화합물 (I-2)을 N-클로로숙신이미드와 반응시켜 4-알킬-1-(4'-(4-알킬사이클로헥실)페닐)이소옥사졸리딘을 제조한다.The corresponding oxime compound (I-2) is formed from 4- (4′-alkylcyclohexyl) benzaldehyde (I-1). The oxime compound (I-2) is reacted with N-chlorosuccinimide to prepare 4-alkyl-1- (4 '-(4-alkylcyclohexyl) phenyl) isoxazolidine.

이하, 본 발명을 실시예를 들어 상세히 설명하기로 하되, 본 발명이 하기 실시예로만 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited only to the following Examples.

합성예 1Synthesis Example 1

1,4-디페닐이소옥사졸리딘의 제조Preparation of 1,4-diphenylisooxazolidine

(1) 4-알콕시벤즈알데히드(1) 4-alkoxybenzaldehyde

4-하이드록시벤즈알데히드 10g(0.082mol)에 알킬브로마이드 (0.080mol)와 탄산칼슘 0.25mol 및 아세톤 20㎖를 부가한 다음, 이 반응 혼합물을 5시간동안 환류시켰다.To 10 g (0.082 mol) of 4-hydroxybenzaldehyde, alkyl bromide (0.080 mol), 0.25 mol of calcium carbonate and 20 ml of acetone were added, and the reaction mixture was refluxed for 5 hours.

상기 반응 혼합물을 냉각시키고 여과한 다음, 감압증류하여 아세톤을 제거했다.The reaction mixture was cooled, filtered and distilled under reduced pressure to remove acetone.

반응 혼합물에 에틸 아세테이트 250㎖, 1M NaOH 50㎖ 및 증류수 50㎖를 부가한 다음, 유기층과 물층을 분리하였다. 모아진 유기층을 건조한 무수 에테르 20㎖에 다음 여과 및 감압증류하여 4-알콕시벤즈알데히드를 얻었다(수율: 90∼95%).250 ml of ethyl acetate, 50 ml of 1M NaOH and 50 ml of distilled water were added to the reaction mixture, and then the organic layer and the water layer were separated. The combined organic layers were then filtered and distilled under reduced pressure in 20 ml of dry anhydrous ether to give 4-alkoxybenzaldehyde (yield: 90 to 95%).

(2) 4-알콕시벤즈알독심(4-alkoxybenzaldoxime)(2) 4-alkoxybenzaldoxime

4-알콕시벤즈알데히드 0.044mol에 에탄올 30㎖를 부가한 다음, 얼음배쓰를 이용하여 반응 혼합물을 냉각하였다. 냉각된 반응 혼합물에 하이드록시아민·염산염(NH2OH·HCl)(0.05mol) 수용액 10㎖와 수산화나트륨(0.06mol) 수용액 10㎖를 순차적으로 부가하였다. 이 때 반응 혼합물의 온도가 약 10℃를 넘지 않도록 조절하였다.30 mL of ethanol was added to 0.044 mol of 4-alkoxybenzaldehyde, and the reaction mixture was cooled using an ice bath. To the cooled reaction mixture, 10 ml of aqueous hydroxyamine hydrochloride (NH 2 OH HCl) (0.05 mol) solution and 10 ml of aqueous sodium hydroxide (0.06 mol) solution were added sequentially. At this time, the temperature of the reaction mixture was adjusted so as not to exceed about 10 ° C.

상기 반응 혼합물을 실온에서 약 2시간동안 교반하고 나서 에틸 아세테이트 500㎖로 추출하였다. 모아진 에틸 아세테이트층을 건조, 여과 및 감압증류하여 4-알콕시벤즈알독심을 얻었다(수율: 85∼92%).The reaction mixture was stirred at room temperature for about 2 hours and then extracted with 500 ml of ethyl acetate. The collected ethyl acetate layers were dried, filtered and distilled under reduced pressure to obtain 4-alkoxybenz aldoxime (yield: 85 to 92%).

(3) 1-(4'-알콕시페닐)-4-(4-아세톡시페닐)이소옥사졸리딘(3) 1- (4'-alkoxyphenyl) -4- (4-acetoxyphenyl) isoxazolidine

4-알콕시벤즈알독심 4.5mmol을 CHCl330㎖에 녹인 다음, N-클로로숙신이미드 4.5mmol를 부가하여 완전히 용해시켰다. 이 반응 혼합물을 실온에서 30분동안 교반한 다음, p-아세톡시스티렌(4.7mmol)의 CHCl3용액 20㎖을 적가하였다.4.5 mmol of 4-alkoxybenz aldoxim was dissolved in 30 mL of CHCl 3 , and then 4.5 mmol of N-chlorosuccinimide was added to dissolve completely. The reaction mixture was stirred at room temperature for 30 minutes and then 20 mL of a solution of CHCl 3 in p-acetoxystyrene (4.7 mmol) was added dropwise.

그 후, 반응 혼합물에 트리에틸아민 (5.4mmol)의 CHCl3(10㎖) 용액을 30분동안 적가하였다.Thereafter, a solution of CHCl 3 (10 mL) of triethylamine (5.4 mmol) was added dropwise to the reaction mixture for 30 minutes.

상기 반응 혼합물을 약 2시간동안 교반한 다음, 증류수 50㎖를 부가하고 클로로포름 (100)㎖로 추출하였다. 이 반응 혼합물을 감압증류하여 클로로포름을 제거한 다음, 에틸아세테이트로 재결정하여 1-(4'-알콕시페닐)-4-(4-아세톡시페닐)이소옥사졸리딘을 얻었다(수율: 45∼70%).The reaction mixture was stirred for about 2 hours, then 50 mL of distilled water was added and extracted with 100 mL of chloroform. The reaction mixture was distilled under reduced pressure to remove chloroform, and then recrystallized from ethyl acetate to obtain 1- (4'-alkoxyphenyl) -4- (4-acetoxyphenyl) isooxazolidine (yield: 45-70%) .

(4) 1-(4'-알콕시페닐)-4-(4-하이드록시페닐)이소옥사졸리딘(4) 1- (4'-alkoxyphenyl) -4- (4-hydroxyphenyl) isoxazolidine

1-(4'-알콕시페닐)-4-(4-아세톡시페닐)이소옥사졸리딘 9.2mmol을 에탄올 190㎖에 녹인 다음, 수산화나트륨(0.046mol) 수용액 40㎖를 부가하였다.9.2 mmol of 1- (4'-alkoxyphenyl) -4- (4-acetoxyphenyl) isooxazolidine was dissolved in 190 ml of ethanol, and then 40 ml of aqueous sodium hydroxide (0.046 mol) solution was added.

상기 반응 혼합물을 50℃에서 12시간동안 교반하고 나서, 에틸 아세테이트를 이용하여 추출하였다. 이 반응 혼합물을 감압증류하여 에틸 아세테이트를 제거한 다음, 에탄올로 재결정하여 1-(4'-알콕시페닐)-4-(4-하이드록시페닐)이소옥사졸리딘을 얻었다(수율: 80∼90%).The reaction mixture was stirred at 50 ° C. for 12 h and then extracted with ethyl acetate. The reaction mixture was distilled under reduced pressure to remove ethyl acetate, and then recrystallized with ethanol to obtain 1- (4'-alkoxyphenyl) -4- (4-hydroxyphenyl) isoxazolidine (yield: 80 to 90%). .

(5) 1-(4'-알콕시페닐)-4-(4-알콕시페닐)이소옥사졸리딘(5) 1- (4'-alkoxyphenyl) -4- (4-alkoxyphenyl) isoxazolidine

1-(4'-알콕시페닐)-4-(4-하이드록시페닐)이소옥사졸리딘 7mmol, 알킬 브로마이드 0.3mmol 및 아세톤 50㎖의 혼합물을 무수조건에서 15시간동안 환류하였다.A mixture of 7 mmol of 1- (4'-alkoxyphenyl) -4- (4-hydroxyphenyl) isoxazolidine, 0.3 mmol of alkyl bromide and 50 ml of acetone was refluxed for 15 hours under anhydrous conditions.

상기 반응 혼합물을 냉각한 다음, 여과 및 감압증류하여 아세톤을 제거하였다.The reaction mixture was cooled, then filtered and distilled under reduced pressure to remove acetone.

상기 반응 결과물을 클로로포름 150㎖로 추출하였다. 모아진 유기층을 건조한 다음, 여과하고 감압증류하였다. 이어서, 에틸 아세테이트로 재결정하여 1-(4'-알콕시페닐)-4-(4-알콕시페닐)이소옥사졸리딘을 얻었다(수율: 60∼80%).The reaction product was extracted with 150 ml of chloroform. The combined organic layers were dried, filtered and distilled under reduced pressure. Subsequently, recrystallization with ethyl acetate gave 1- (4'-alkoxyphenyl) -4- (4-alkoxyphenyl) isooxazolidine (yield: 60 to 80%).

합성예 2Synthesis Example 2

1-페닐-4-알킬이소옥사졸리딘의 제조Preparation of 1-phenyl-4-alkylisoxazolidine

(1) 4-(4'-알콕시페닐카르보닐)옥시벤즈알데히드(1) 4- (4'-alkoxyphenylcarbonyl) oxybenzaldehyde

4-알콕시벤조산 0.02mmol에 티오닐 클로라이드(SOCl2) 0.1mol을 부가한 다음, 무수조건에서 2시간동안 환류하였다. 반응 혼합물을 감압증류하여 과량의 티오닐 클로라이드를 제거한 다음, 무수 에테르 10㎖에 녹였다.0.1 mol of thionyl chloride (SOCl 2 ) was added to 0.02 mmol of 4-alkoxybenzoic acid, and the mixture was refluxed under anhydrous conditions for 2 hours. The reaction mixture was distilled under reduced pressure to remove excess thionyl chloride and then dissolved in 10 ml of anhydrous ether.

상기 반응 혼합물에, 4-하이드록시벤즈알데히드(0.025mmol)와 피리딘(5㎖)의 무수에테르 용액 30㎖을 30분동안 적가하였다.To the reaction mixture, 30 mL of anhydrous ether solution of 4-hydroxybenzaldehyde (0.025 mmol) and pyridine (5 mL) was added dropwise for 30 minutes.

반응 혼합물을 실온에서 약 2시간동안 교반한 다음, 에테르 250㎖로 추출하였다. 상기 에테르층을 1M HCl 수용액으로 세척한 다음, 건조, 여과 및 감압증류하였다. 이어서, 상기 결과물에 대해 칼럼 크로마토그래피를 실시하여 4-(4'-알콕시페닐카르보닐)옥시벤즈알데히드를 얻었다(수율: 60-85%).The reaction mixture was stirred at rt for about 2 h and then extracted with 250 mL of ether. The ether layer was washed with 1M aqueous HCl solution, then dried, filtered and distilled under reduced pressure. Subsequently, column chromatography was performed on the resultant to obtain 4- (4'-alkoxyphenylcarbonyl) oxybenzaldehyde (yield: 60-85%).

(2) 4-(4'-알콕시페닐카르보닐옥시)벤즈알독심(2) 4- (4'-alkoxyphenylcarbonyloxy) benz aldoxime

4-(4'-알콕시페닐카르보닐)벤즈알데히드 9.3mmol을 에탄올 100㎖에 용해한 다음, 얼음배쓰를 이용하여 반응 혼합물을 냉각하였다.9.3 mmol of 4- (4'-alkoxyphenylcarbonyl) benzaldehyde was dissolved in 100 ml of ethanol and the reaction mixture was cooled using an ice bath.

냉각된 반응 혼합물에 하이드록시아민·염산염(9.7mmol) 수용액 20㎖과 탄산칼슘(9.7mmol) 수용액 20㎖를 부가하는데, 이 때 반응 혼합물의 온도가 10℃가 넘지 않도록 조절하였다.To the cooled reaction mixture, 20 ml of hydroxyamine hydrochloride (9.7 mmol) aqueous solution and 20 ml of calcium carbonate (9.7 mmol) aqueous solution were added, at which time the temperature of the reaction mixture was adjusted to not exceed 10 ° C.

상기 반응 혼합물을 실온에서 약 5시간동안 교반한 다음, 감압증류하여 에탄올을 제거했다. 이어서, 상기 결과물을 에틸 아세테이트 50㎖로 추출하였다.The reaction mixture was stirred at room temperature for about 5 hours and then distilled under reduced pressure to remove ethanol. The resultant was then extracted with 50 ml of ethyl acetate.

모아진 유기층을 건조한 다음, 여과 및 감압증류하여 4-(4'-알콕시페닐카르보닐옥시)벤즈알독심을 얻었다(수율: 55∼70%).The combined organic layers were dried, filtered and distilled under reduced pressure to obtain 4- (4'-alkoxyphenylcarbonyloxy) benzaldehyde, which was yielded from 55 to 70%.

(3) 1-(4'-알콕시페닐카르보닐옥시)페닐-4-알킬이소옥사졸리딘(3) 1- (4'-alkoxyphenylcarbonyloxy) phenyl-4-alkylisoxazolidine

4-(4'-알콕시페닐카르보닐옥시)벤즈알독심 1.3mmol을 CHCl330㎖에 녹인 다음, N-클로로숙신이미드 1.36mmol을 부가하여 완전히 용해시켰다.1.3 mmol of 4- (4'-alkoxyphenylcarbonyloxy) benzaldoxim was dissolved in 30 ml of CHCl 3 , followed by the addition of 1.36 mmol of N-chlorosuccinimide to complete dissolution.

상기 반응 혼합물을 실온에서 약 30분동안 교반한 다음, 올레핀(1.36mmol)의 CHCl3(5㎖) 용액을 적가하였다. 이어서, 트리에틸아민(1.43mmol)의 CHCl3(3㎖) 용액을 10분에 걸쳐 적가하였다.The reaction mixture was stirred at rt for about 30 min and then a CHCl 3 (5 mL) solution of olefin (1.36 mmol) was added dropwise. Then a solution of CHCl 3 (3 mL) of triethylamine (1.43 mmol) was added dropwise over 10 minutes.

반응 혼합물을 2시간동안 교반하여 반응을 완결시켰다. 이어서, 반응 혼합물에 증류수 30㎖와 클로로포름 50㎖를 부가하여 물층과 유기층을 분리함으로써 클로로포름층을 추출하였다.The reaction mixture was stirred for 2 hours to complete the reaction. Subsequently, 30 ml of distilled water and 50 ml of chloroform were added to the reaction mixture to separate the water layer and the organic layer, thereby extracting the chloroform layer.

모아진 유기층을 건조한 다음, 여과하고 감압증류하였다. 이 결과물을 에틸 아세테이트를 이용하여 재결정하여 1-(4'-알콕시페닐카르보닐옥시)페닐-4-알킬이소옥사졸리딘을 얻었다(수율: 40∼50%).The combined organic layers were dried, filtered and distilled under reduced pressure. The resulting product was recrystallized using ethyl acetate to obtain 1- (4'-alkoxyphenylcarbonyloxy) phenyl-4-alkylisoxazolidine (yield: 40-50%).

상기 1-(4'-알콕시페닐카르보닐옥시)페닐-4-알킬이소옥사졸리딘의 온도에 따른 상형태는 다음과 같다.The phase form according to the temperature of said 1- (4'-alkoxyphenylcarbonyloxy) phenyl-4-alkylisoxazolidine is as follows.

C 111.5℃ SC116.5℃ Sa162.4℃ N 162.8 IC 111.5 ℃ S C 116.5 ℃ S a 162.4 ℃ N 162.8 I

여기서, C는 결정성 고체를, SC는 스메틱 c상을, Sa는 스메틱 a상을, N은 네마틱상을, I는 등방성 상을 표시한다. 이 때 상전이 온도 및 액정상은 편광 현미경이 부착된 핫 스테이지를 이용하여 측정하였다.Here, C represents a crystalline solid, S C represents a smematic c phase, S a represents a smematic a phase, N represents a nematic phase, and I represents an isotropic phase. At this time, the phase transition temperature and the liquid crystal phase were measured using a hot stage with a polarizing microscope.

합성예 3Synthesis Example 3

비페닐이소옥사졸리딘의 제조Preparation of Biphenylisooxazolidine

(1) 4-(4'-알킬페닐)벤질알콜(1) 4- (4'-alkylphenyl) benzyl alcohol

수소화알루미늄리튬(LAH, 8.6mmol)의 무수 THF(20㎖) 용액에 에틸 4-(4'-알킬페닐)벤조에이트(3.6mmol)의 무수 THF (10)㎖) 용액을 25분동안 적가하였다. 얼음 배쓰를 이용하여 반응 혼합물을 냉각한 다음, 물 10㎖를 부가하여 반응을 종결시켰다.To anhydrous THF (20 mL) solution of lithium aluminum hydride (LAH, 8.6 mmol) was added dropwise anhydrous THF (10) mL) solution of ethyl 4- (4'-alkylphenyl) benzoate (3.6 mmol) for 25 minutes. The reaction mixture was cooled using an ice bath, then 10 ml of water was added to terminate the reaction.

반응 혼합물을 에틸 아세테이트 200㎖로 추출하고, 이 유기층을 건조 및 여과하였다. 상기 결과물을 감압증류하고 나서, 칼럼 크로마토그래피를 실시하여 4-(4'-알킬페닐)벤질알콜을 얻었다(수율: 75%).The reaction mixture was extracted with 200 ml of ethyl acetate and the organic layer was dried and filtered. The resultant was distilled under reduced pressure, and column chromatography was carried out to obtain 4- (4'-alkylphenyl) benzyl alcohol (yield: 75%).

(2) 4-(4'-알킬페닐)벤즈알데히드(2) 4- (4'-alkylphenyl) benzaldehyde

피리디늄 클로로크로메이트(pyridinium chlorochromate(PCC), 7.3mmol)의 메틸렌클로라이드(40㎖) 용액에 4-(4'-알킬페닐)벤질알콜(10㎖)의 메틸렌 클로라이드 (10㎖) 용액을 30분동안 적가하였다. 반응 혼합물을 실온에서 5시간동안 교반한 다음, 메틸렌클로라이드 250㎖로 추출하였다.To a methylene chloride (40 mL) solution of pyridinium chlorochromate (PCC) (7.3 mmol) was added a solution of 4- (4'-alkylphenyl) benzyl alcohol (10 mL) of methylene chloride (10 mL) for 30 minutes. Added dropwise. The reaction mixture was stirred at rt for 5 h and then extracted with 250 ml of methylene chloride.

모아진 유기층을 건조, 여과 및 감압증류하였다. 이 결과물에 대해 칼럼 크로마토그래피를 실시하여 4-(4'-알킬페닐)벤즈알데히드를 얻었다(수율: 90%).The combined organic layers were dried, filtered and distilled under reduced pressure. This product was subjected to column chromatography to obtain 4- (4'-alkylphenyl) benzaldehyde (yield: 90%).

(3) 4-(4'-알킬페닐)벤즈알독심(3) 4- (4'-alkylphenyl) benz aldoxime

4-(4'-알킬페닐)벤즈알데히드 3.51mmol을 에탄올 20㎖에 용해한 다음, 얼음배쓰를 이용하여 반응 혼합물을 냉각하였다. 냉각된 반응 혼합물에 하이드록시아민·염산염 (4.2mmol) 수용액 10 ㎖와 수산화나트륨(4.2mmol) 수용액 10 ㎖를 순차적으로 부가하였다. 이 때 반응 혼합물의 온도가 10℃가 넘지 않도록 조절하였다.3.51 mmol of 4- (4'-alkylphenyl) benzaldehyde was dissolved in 20 ml of ethanol and the reaction mixture was cooled using an ice bath. To the cooled reaction mixture, 10 ml of aqueous hydroxyamine hydrochloride (4.2 mmol) solution and 10 ml of aqueous sodium hydroxide (4.2 mmol) solution were added sequentially. At this time, the temperature of the reaction mixture was adjusted to not exceed 10 ° C.

상기 반응 혼합물을 실온에서 5시간동안 교반한 다음, 감압증류하여 에탄올을 제거했다. 에틸 아세테이트 500㎖로 추출한 다음, 건조 및 여과하고 감압증류하여 4-(4'-알킬페닐)벤즈알독심을 얻었다(수율: 70%).The reaction mixture was stirred at room temperature for 5 hours and then distilled under reduced pressure to remove ethanol. Extracted with 500 ml of ethyl acetate, dried, filtered, and distilled under reduced pressure to obtain 4- (4'-alkylphenyl) benzaldehyde.

(4) 4-알킬-1-(4'-알킬비페닐)이소옥사졸리딘(4) 4-alkyl-1- (4'-alkylbiphenyl) isoxazolidine

4-(4'-알킬페닐)벤즈알독심 3.6mmol을 CHCl330㎖에 녹인 다음, 여기에 N-클로로숙신이미드 3.6mmol을 부가하여 완전히 용해시켰다.3.6 mmol of 4- (4'-alkylphenyl) benzaldoxim was dissolved in 30 mL of CHCl 3 , and then 3.6 mmol of N-chlorosuccinimide was added thereto to dissolve completely.

상기 반응 혼합물을 실온에서 30분동안 교반한 다음, 올레핀(4.0mmol)의 CHCl3(10㎖) 용액을 부가하였다. 그 후, 상기 반응 혼합물에 트리에틸아민 (3.( )mmol)의 CHCl3(5㎖) 용액을 10분동안 적가하였다.The reaction mixture was stirred for 30 minutes at room temperature, then a solution of CHCl 3 (10 mL) of olefin (4.0 mmol) was added. Thereafter, a solution of CHCl 3 (5 mL) of triethylamine (3. () mmol) was added dropwise to the reaction mixture for 10 minutes.

상기 반응 혼합물을 2시간동안 교반한 다음, 증류수 30㎖와 클로로포름 50㎖를 부가하여 클로로포름층을 추출하였다. 모아진 유기층을 감압증류한 다음, 이 결과물을 에틸 아세테이트로 재결정하여 4-알킬-1-(4'-알킬비페닐)이소옥사졸리딘을 얻었다(수율: 60%).The reaction mixture was stirred for 2 hours, and then 30 ml of distilled water and 50 ml of chloroform were added to extract a chloroform layer. The combined organic layers were distilled under reduced pressure, and the resultant was recrystallized from ethyl acetate to obtain 4-alkyl-1- (4'-alkylbiphenyl) isoxazolidine (yield: 60%).

상기 4-알킬-1-(4'-알킬비페닐)이소옥사졸리딘의 온도에 따른 상형태는 다음과 같다.The phase form of the 4-alkyl-1- (4'-alkylbiphenyl) isooxazolidine according to the temperature is as follows.

C 152℃ ? 168℃ IC 152 ℃? 168 ° C I

(5) 4-아밀-4'-(1-하이드록시에틸)비페닐(5) 4-amyl-4 '-(1-hydroxyethyl) biphenyl

4-아세틸-4'-아밀비페닐 0.017mol, 수소화붕소나트륨 0.025mol 및 에탄올 10㎖의 혼합물을 5시간동안 환류하였다.A mixture of 0.017 mol of 4-acetyl-4'-amylbiphenyl, 0.025 mol of sodium borohydride and 10 ml of ethanol was refluxed for 5 hours.

반응이 완결되면, 반응 혼합물을 에틸 아세테이트 50㎖로 추출하였다. 에틸 아세테이트층을 감압증류한 다음, 에탄올로 재결정하여 4-아밀-4'-(1-하이드록시에틸)비페닐을 얻었다(수율: 72%).Upon completion of the reaction, the reaction mixture was extracted with 50 ml of ethyl acetate. The ethyl acetate layer was distilled under reduced pressure and then recrystallized with ethanol to give 4-amyl-4 '-(1-hydroxyethyl) biphenyl (yield: 72%).

(6) 4-아밀-4'-비닐비페닐(6) 4-amyl-4'-vinylbiphenyl

4-아밀-4'-(1-하이드록시에틸)비페닐 0.70g(2.36mmol)과 20%의 H2SO4수용액 60㎖의 혼합물을 1시간동안 환류시켰다.A mixture of 0.70 g (2.36 mmol) of 4-amyl-4 '-(1-hydroxyethyl) biphenyl and 60 mL of 20% aqueous H 2 SO 4 solution was refluxed for 1 hour.

반응 혼합물을 에틸 아세테이트로 추출하고 칼럼 크로마토그래피를 실시하여 4-아밀-4'-비닐비페닐 0.14g을 얻었다(수율: 21%).The reaction mixture was extracted with ethyl acetate and subjected to column chromatography to give 0.14 g of 4-amyl-4'-vinylbiphenyl (yield: 21%).

(7) 헵타알독심(heptaldoxime)(7) heptaldoxime

알킬 알데히드 0.18mmol을 에탄올 50㎖에 용해한 다음, 얼음배쓰를 이용하여 반응 혼합물을 냉각하였다. 반응 혼합물에 하이드록시아민·염산염(0.20mol) 수용액 20㎖와 수산화나트륨(0.06mol) 수용액 20㎖를 순차적으로 부가하였다. 이 때 반응 혼합물의 온도가 약 10℃를 넘지 않도록 조절하였다.0.18 mmol of alkyl aldehydes were dissolved in 50 mL of ethanol and the reaction mixture was cooled using an ice bath. 20 ml of aqueous hydroxyamine hydrochloride (0.20 mol) solution and 20 ml of sodium hydroxide (0.06 mol) aqueous solution were sequentially added to the reaction mixture. At this time, the temperature of the reaction mixture was adjusted so as not to exceed about 10 ° C.

반응 혼합물을 실온에서 5시간동안 교반한 다음, 감압증류하여 에탄올을 제거했다. 상기 결과물을 에틸 아세테이트 500㎖로 추출한 다음, 건조, 여과 및 감압증류하여 헵타알독심을 얻었다(수율: 90%).The reaction mixture was stirred at room temperature for 5 hours and then distilled under reduced pressure to remove ethanol. The resulting product was extracted with 500 ml of ethyl acetate, then dried, filtered and distilled under reduced pressure to obtain hepta aldoxin (yield: 90%).

(8) 1-프로필-4-(4'-아밀비페닐)이소옥사졸리딘(8) 1-propyl-4- (4'-amylbiphenyl) isoxazolidine

헵타알독심(heptaldoxime) 1.8mmol을 CHCl330㎖에 녹이고 나서, 여기에 N-클로로숙신이미드 1.8mmol을 부가하여 완전히 용해시켰다.1.8 mmol of heptaldoxime was dissolved in 30 mL of CHCl 3 , and then 1.8 mmol of N-chlorosuccinimide was added thereto to completely dissolve it.

상기 반응 혼합물을 실온에서 30분동안 교반한 다음, 4-아밀-4'-비닐비페닐 (2mmol)의 CHCl3(10㎖) 용액을 부가하였다. 그 후, 상기 반응 혼합물에 트리에틸아민 (2.0mmol)의 CHCl3(5㎖) 용액을 10분동안 적가하였다.The reaction mixture was stirred for 30 minutes at room temperature, then a solution of CHCl 3 (10 mL) of 4-amyl-4'-vinylbiphenyl (2 mmol) was added. Thereafter, a solution of CHCl 3 (5 mL) of triethylamine (2.0 mmol) was added dropwise to the reaction mixture for 10 minutes.

상기 반응 혼합물을 2시간동안 교반한 다음, 증류수 30㎖와 클로로포름 50㎖를 부가하여 클로로포름층을 추출하였다. 모아진 유기층을 감압증류하고 이를 에틸 아세테이트로 재결정하여 1-프로필-4-(4'-아밀비페닐)이소옥사졸리딘을 얻었다(수율: 35%).The reaction mixture was stirred for 2 hours, and then 30 ml of distilled water and 50 ml of chloroform were added to extract a chloroform layer. The combined organic layers were distilled under reduced pressure and recrystallized with ethyl acetate to obtain 1-propyl-4- (4'-amylbiphenyl) isooxazolidine (yield: 35%).

합성예 4Synthesis Example 4

사이클로헥실페닐이소옥사졸리딘의 제조Preparation of Cyclohexylphenylisoxazolidine

(1) 4-(4'-트란스-아밀옥시사이클로헥실)벤즈알데히드(1) 4- (4'-trans-amyloxycyclohexyl) benzaldehyde

4-(4'-트란스-아밀사이클로헥실)벤즈알데히드 0.017mol을 에탄올 50㎖에 녹인 다음, 얼음 배쓰를 이용하여 반응 혼합물을 냉각하였다.0.017 mol of 4- (4'-trans-amylcyclohexyl) benzaldehyde was dissolved in 50 ml of ethanol and the reaction mixture was cooled using an ice bath.

상기 반응 혼합물에 하이드록시아민·염산염(0.02mol) 수용액 10㎖와 탄산칼슘(2.85g, 0.02mol) 수용액 20㎖를 순차적으로 부가하는데, 이 때 반응 혼합물의 온도가 약 10℃를 넘지 않도록 조절하였다.10 ml of hydroxyamine hydrochloride (0.02 mol) aqueous solution and 20 ml of calcium carbonate (2.85 g, 0.02 mol) aqueous solution were sequentially added to the reaction mixture, at which time the temperature of the reaction mixture was adjusted not to exceed about 10 ° C. .

반응 혼합물을 실온에서 5시간동안 교반한 다음, 감압증류하여 에탄올을 제거하였다. 상기 결과물을 에틸 아세테이트 500㎖로 추출한 다음, 건조, 여과 및 감압증류하여 4-(4'-트란스-아밀옥시사이클로헥실)벤즈알데히드를 얻었다(수율: 73%).The reaction mixture was stirred at room temperature for 5 hours and then distilled under reduced pressure to remove ethanol. The resulting product was extracted with 500 ml of ethyl acetate, dried, filtered and distilled under reduced pressure to obtain 4- (4'-trans-amyloxycyclohexyl) benzaldehyde (yield: 73%).

(2) 4-프로필-1-(4'-(4-아밀사이클로헥실)페닐)이소옥사졸리딘(2) 4-propyl-1- (4 '-(4-amylcyclohexyl) phenyl) isoxazolidine

4-(4'-트란스-아밀옥시사이클로헥실)벤즈알데히드 3.3mmol을 CHCl330㎖에 녹이고 나서, 여기에 N-클로로숙신이미드 3.6mmol을 부가하여 완전히 용해시켰다.3.3 mmol of 4- (4′-trans-amyloxycyclohexyl) benzaldehyde was dissolved in 30 ml of CHCl 3 , and 3.6 mmol of N-chlorosuccinimide was added thereto to dissolve completely.

상기 반응 혼합물을 실온에서 30분동안 교반한 다음, 헵텐(3.94mmol)의 CHCl3(10㎖) 용액을 부가하였다. 그 후, 상기 반응 혼합물에 트리에틸아민 0.38g(3.8mmol)의 CHCl3(10㎖) 용액을 10분동안 적가하였다.The reaction mixture was stirred at room temperature for 30 minutes, then a solution of CHCl 3 (10 mL) in heptene (3.94 mmol) was added. Thereafter, 0.38 g (3.8 mmol) of CHCl 3 (10 mL) solution of triethylamine was added dropwise to the reaction mixture for 10 minutes.

상기 반응 혼합물을 2시간동안 교반한 다음, 증류수 100㎖와 클로로포름 100㎖를 부가하여 클로로포름층을 추출하였다. 모아진 유기층을 감압증류한 다음, 에틸 아세테이트로 2회 재결정하여 4-프로필-1-(4'-(4-아밀사이클로헥실)페닐)이소옥사졸리딘을 얻었다(수율: 35%).The reaction mixture was stirred for 2 hours, and then 100 ml of distilled water and 100 ml of chloroform were added to extract a chloroform layer. The combined organic layers were distilled under reduced pressure and then recrystallized twice with ethyl acetate to obtain 4-propyl-1- (4 '-(4-amylcyclohexyl) phenyl) isoxazolidine (yield: 35%).

상기 4-프로필-1-(4'-(4-아밀사이클로헥실)페닐)이소옥사졸리딘의 온도에 따른 상형태는 다음과 같다.The phase form according to the temperature of the 4-propyl-1- (4 '-(4-amylcyclohexyl) phenyl) isooxazolidine is as follows.

C 156℃ ? 172℃ IC 156 ℃? 172 ℃ I

상기 합성예에 따라 제조된 액정 화합물의 결정성 고체로부터 스멕틱상으로 전이되는 온도는, 통상적인 경우에 비하여 낮아짐을 알 수 있었다.It was found that the temperature of transition from the crystalline solid to the smectic phase of the liquid crystal compound prepared according to the synthesis example was lower than in the conventional case.

본 발명에 따른 이소옥사졸리딘 고리 함유 액정 화합물은 화학적으로 안정하고, 결정성 고체로부터 스멕틱상으로 전이되는 온도가 낮기 때문에 스멕틱상을 형성하기가 매우 용이하다. 이러한 액정 화합물은 액정 조성물의 구성요소로 이용될 뿐만 아니라, 합성 중간체로서 다른 종류의 액정 화합물을 합성하는데 이용된다.The isoxazolidine ring-containing liquid crystal compound according to the present invention is chemically stable, and it is very easy to form a smectic phase because of the low temperature transition from the crystalline solid to the smectic phase. These liquid crystal compounds are not only used as components of the liquid crystal composition, but also used to synthesize other kinds of liquid crystal compounds as synthetic intermediates.

또한, 본 발명에 따른 액정 화합물을 포함하고 있는 액정 조성물은 복굴절율, 유전율 이방성 등을 적절히 조절하면 여러 가지 액정표시소자에 매우 유용하게 적용할 수 있다.In addition, the liquid crystal composition containing the liquid crystal compound according to the present invention can be very usefully applied to various liquid crystal display devices by appropriately adjusting birefringence, dielectric anisotropy, and the like.

Claims (7)

화학식 1의 이소옥사졸리딘 고리 함유 액정 화합물:Ioxoxazolidine ring-containing liquid crystal compound of Formula 1: 상기식중, R1과 R2중의 적어도 하나는 하기 구조식으로 표시되는 그룹이고,Wherein at least one of R 1 and R 2 is a group represented by the following structural formula, 여기에서, Z1는 COO, OOC, CH2CH2, OCH2, CH2O, C≡C, CH=CH 또는 CH2이고,Wherein Z 1 is COO, OOC, CH 2 CH 2 , OCH 2 , CH 2 O, C≡C, CH = CH or CH 2 , X1, X2, X3, X4, X5, X5, X7그리고 X8은 서로에 관계없이, H, F 또는 Cl이고,X 1 , X 2 , X 3 , X 4 , X 5 , X 5 , X 7 and X 8 , regardless of each other, are H, F or Cl, R3는 CnH2n+1, OCnH2n+1, SCnH2n+1, C(=O)CnH2n+1, OOC-CnH2n+1, COOCnH2n+1, 또는 NHCnH2n+1(단, n는 1-12의 정수임);R 3 is C n H 2n + 1 , OC n H 2n + 1 , SC n H 2n + 1 , C (= O) C n H 2n + 1 , OOC-C n H 2n + 1 , COOC n H 2n + 1 , or NHC n H 2n + 1 , where n is an integer from 1-12; 나머지 R1또는 R2는 비치환된 C1∼C12직쇄형 또는 분지형 알킬기, F, Cl, Br, CF3, OCF3및 CN중에서 선택된 적어도 하나의 치환기로 치환된 C1∼C12직쇄형 또는 분지형 알킬기(단, 한 개의 -CH2- 또는 인접하지 않은 두 개의 -CH2-는 -O-, -S-, -CO-, -OCO-, -COO-, -OCS-, -COS- 및 -CH=CH-에 의하여 치환되어 있으며, 말단기(terminal group)로서 -CH=CH2및/또는 -CH=C(CH3)2를 갖고 있음), 사이클로헥실기, 페닐기, 4-알킬사이클로헥실기, 4-알킬페닐기, 4-알콕시페닐기(단, 알킬기는 C1∼C6알킬기임)중에서 선택된 하나이다.The remaining R 1 or R 2 is unsubstituted C 1 ~C 12 straight-chain or branched alkyl, F, Cl, Br, CF 3, OCF 3 and substituted with at least one substituent selected from C 1 ~C 12 straight-CN A chain or branched alkyl group, provided that one -CH 2 -or two non-adjacent -CH 2 -is -O-, -S-, -CO-, -OCO-, -COO-, -OCS-,- Substituted by COS- and -CH = CH- and having -CH = CH 2 and / or -CH = C (CH 3 ) 2 as a terminal group), a cyclohexyl group, a phenyl group, 4 -An alkylcyclohexyl group, a 4-alkylphenyl group, or a 4-alkoxyphenyl group, provided that the alkyl group is a C 1 to C 6 alkyl group. 제1항에 있어서, 상기 R1과 R2중의 적어도 하나는The method of claim 1, wherein at least one of R 1 and R 2 is (상기식중, Z3는 화학결합(chemical bond)으로서, 산소원자, 황원자 또는 카르복실기이고, R4는 C6∼C12직쇄형 또는 분지형 포화알킬기임)(Wherein Z 3 is a chemical bond, an oxygen atom, a sulfur atom or a carboxyl group, and R 4 is a C 6 to C 12 straight or branched saturated alkyl group) 로 이루어진 군으로부터 선택되는 것을 특징으로 하는 이소옥사졸리딘 고리 함유 액정 화합물.Isooxazolidine ring-containing liquid crystal compound, characterized in that selected from the group consisting of. 제1항에 있어서, 상기 액정 화합물이 화학식 2로 표시되는 화합물인 것을 특징으로 하는 이소옥사졸리딘 고리 함유 액정 화합물.The isooxazolidine ring-containing liquid crystal compound according to claim 1, wherein the liquid crystal compound is a compound represented by the formula (2). 상기식중, Y1과 Y2는 서로에 관계없이, CnH2n+1(n은 1 내지 8의 수임)이다.In the above formula, Y 1 and Y 2 are C n H 2n + 1 (n is a number from 1 to 8) irrespective of each other. 제1항에 있어서, 상기 액정 화합물이 화학식 3으로 표시되는 화합물인 것을 특징으로 하는 이소옥사졸리딘 고리 함유 액정 화합물:The isoxoxazolidine ring-containing liquid crystal compound according to claim 1, wherein the liquid crystal compound is a compound represented by Chemical Formula 3. 상기식중, Y3과 Y4는 서로에 관계없이, CnH2n+1(n은 1 내지 8의 수임)이다.In the above formula, Y 3 and Y 4 are C n H 2n + 1 (n is a number from 1 to 8) irrespective of each other. 제1항에 있어서, 상기 액정 화합물이 화학식 4 또는 5로 표시되는 화합물인 것을 특징으로 하는 이소옥사졸리딘 고리 함유 액정 화합물:The isoxoxazolidine ring-containing liquid crystal compound according to claim 1, wherein the liquid crystal compound is a compound represented by Chemical Formula 4 or 5. 상기식중, Y5와 Y6는 서로에 관계없이, CnH2n+1(n은 1 내지 8의 수임)이다.In the above formula, Y 5 and Y 6 are C n H 2n + 1 (n is a number from 1 to 8) irrespective of each other. 제1항에 있어서, 상기 액정 화합물이 화학식 6으로 표시되는 화합물인 것을 특징으로 하는 이소옥사졸리딘 고리 함유 액정 화합물:The isoxoxazolidine ring-containing liquid crystal compound according to claim 1, wherein the liquid crystal compound is a compound represented by Chemical Formula 6. 상기식중, Y7과 Y8은 서로에 관계없이, CnH2n+1(n은 1 내지 8의 수임)이다.In the above formula, Y 7 and Y 8 are C n H 2n + 1 (n is a number from 1 to 8) irrespective of each other. 제1항 내지 제6항중 어느 한 항에 따른 이소옥사졸리딘 고리 함유 액정 화합물을 포함하고 있는 액정 조성물.The liquid crystal composition containing the isooxazolidine ring containing liquid crystal compound as described in any one of Claims 1-6.
KR1019970034003A 1997-07-21 1997-07-21 Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same KR19990011062A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970034003A KR19990011062A (en) 1997-07-21 1997-07-21 Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970034003A KR19990011062A (en) 1997-07-21 1997-07-21 Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same

Publications (1)

Publication Number Publication Date
KR19990011062A true KR19990011062A (en) 1999-02-18

Family

ID=66040207

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970034003A KR19990011062A (en) 1997-07-21 1997-07-21 Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same

Country Status (1)

Country Link
KR (1) KR19990011062A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6054375A (en) * 1983-09-01 1985-03-28 Chisso Corp Isoxazole compound
JPS6470476A (en) * 1987-09-10 1989-03-15 Seitetsu Kagaku Co Ltd Production of isoxazoline derivative and/or isoxazole derivative
JPH04234857A (en) * 1990-04-12 1992-08-24 Hoechst Ag 3,5-disubstituted 2-isoquinazoline and isoxazole, process for producing same and pharmaceutical composition containing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6054375A (en) * 1983-09-01 1985-03-28 Chisso Corp Isoxazole compound
JPS6470476A (en) * 1987-09-10 1989-03-15 Seitetsu Kagaku Co Ltd Production of isoxazoline derivative and/or isoxazole derivative
JPH04234857A (en) * 1990-04-12 1992-08-24 Hoechst Ag 3,5-disubstituted 2-isoquinazoline and isoxazole, process for producing same and pharmaceutical composition containing same

Similar Documents

Publication Publication Date Title
US4961876A (en) Liquid crystalline ferroelectric derivatives of branched acyclic alpha-chlorocarboxylic acids
JP4691893B2 (en) Liquid crystal composition, display element and compound containing trifluoronaphthalene derivative.
EP0375670B1 (en) Process for preparing 3-polyfluoroalkylisoxazolylamines
EP0044759A1 (en) Smectic type A liquid crystal with positive dielectric anisotropy
JP5526686B2 (en) Difluorobenzene derivatives and liquid crystal compositions containing the same.
KR19990011062A (en) Ixoxazolidine ring-containing liquid crystal compound and liquid crystal composition containing the same
JP2787602B2 (en) Isoxazoline derivative
Gallardo et al. The synthesis and liquid crystal properties of some series homologues of 1, 2, 4-oxadiazole derivatives
US5328643A (en) Optically active compounds, liquid crystal composition containing said compounds, and liquid crystal optical modulator using said composition
EP0427166B1 (en) Ester compounds and liquid crystal compositions containing the same
KR20010005943A (en) Process for preparing 0-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
Kelly et al. 2-(4-Alkylphenyl)-5-(alkenyloxy) pyrimidines: Synthesis, liquid crystal transition temperatures and some physical properties
JP4496770B2 (en) 1-halogeno-2-alkoxynaphthalene derivative and method for producing the same
JPH0794446B2 (en) 2-phenylpyrimidine derivative
Kaszynski et al. A Comprehensive Approach to (S)-(—)-2-Methyl-1-Butanol as a Convenient Precursor for Synthesis of Chiral Liquid Crystals1
JPH01221351A (en) Tolan compound and liquid crystal composition
US4560785A (en) Phenylacetic ester derivatives and process for preparing the same
Chen et al. 2, 3-Difluorinated phenyl and cyclohexane units in the design and synthesis of liquid crystals having negative dielectric anisotropy
US4931209A (en) Liquid crystalline materials and method of making
JPH0534351B2 (en)
US5360575A (en) Lactic acid derivatives having two asymmetric carbon atoms, liquid crystal composition containing same and liquid crystal device
JPH02153A (en) Liquid crystal device
JP2515546B2 (en) Optically active benzoic acid compound
PT et al. Synthesis and characterization of new homologous series of unsymmetrical liquid crystalline compounds based on chalcones and 3, 5-disubstituted isoxazoles
JP2577398B2 (en) Novel optically active Schiff base compound and method for producing the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application